The webinar includes discussion of the latest European biotech patent case law developments including:

• T966/18 (Prothena Biosciences Limited) - when does preclinical data plausibly support a therapeutic effect?
• T799/16 (Acorda Therapeutics Inc) - dosage regimes - navigating the sufficiency and inventive step requirements.
• T0096/20 (Alexion Pharmaceuticals Inc) - clinical trial protocols as prior art.
• T116/18 (Sumitomo Chemical Company) - referral to the Enlarged Board of Appeal regarding when post-published data can be taken into account for inventive step.
• G1/21 - when can an appeal board order oral proceedings by videoconference (ViCo)?
• G4/19 - double patenting.

System requirements

To view our webinars we recommend the following internet browsers:

• Google Chrome (most recent 2 versions).
• Mozilla Firefox (most recent 2 versions).
• Apple Safari (most recent 2 versions).
• Microsoft Edge (most recent 2 versions).